Device Trial Radar · NCT04776174
Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Mar 1, 2021
Primary completion
Nov 3, 2021
Study completion Nov 3, 2021
Sponsor
- Lead sponsor
- Centre Hospitalier Intercommunal CreteilAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- ADECHOTECH
- First posted
- Mar 1, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 1 year, up to 10 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In children with Covid-19, the diagnosis of Kawasaki Disease (KD) and pneumonia should be made very quickly. However, the regional hospitals surrounding Paris don't have the required expertise. The use of MELODY allows the paediatric team to quickly carry out the necessary examinations while avoiding the movement of patients and the risk of contamination. The MELODY remote system developed by the company AdEchoTech is a CE marking telemedicine technique, allowing an expert to perform an ultrasound scan on a distant patient (several hundred/thousands of kms). The Melody system makes it possible to optimize ultrasound expertise resources wherever they are located (all specialties combined) The feasibility of the clinical use of telerobotic sonography has been demonstrated in adults for abdominal, cardiac and prenatal exam. Thus, the aim of this study is to assess the feasibility of this system in children.
Conditions
- Covid19
Interventions
Ultrasound using the telerobotic Melody systemDevice
The children will first have a telerobotic ultrasound abdominal, pulmonary or cardiac followed by a classical ultrasound.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Agreement Between Telerobotic and Conventional Ultrasound Examinations Assessed by Cohen Kappa CoefficientTime frame: 1 day
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
CHI Créteil
Créteil, France
CHI Villeneuve-Saint-Georges
Villeneuve-Saint-Georges, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.